Immunospatial tumor microenvironment analysis identifies B cell aggregates associated with recurrence-free survival in primary melanoma
Cancer Immunology, Immunotherapy · 20.08.2026 · 75 (12)
DOI: 10.1007/s00262-026-04514-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 20.08.2026. Verfasst von Grace H Attrill und 14 weiteren Autor:innen. Beteiligte Einrichtung: Melanoma Institute Australia, The University of Sydney, Sydney, Australia. Hauptthemen laut MEDLINE: Tumor Microenvironment, Melanoma, B-Lymphocytes. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, The University of Sydney.
Abstract (Originalsprache)
The complex spatial cellular interactions of immune cell populations within melanoma can provide insight into immune functions occurring within tumors. Tertiary lymphoid structures (TLSs) and B cell aggregates (BssCAs) are key features in the immunospatial tumor microenvironment (isTIME), yet are difficult to accurately detect and are poorly understood in primary melanoma. This study utilized mIHC and novel spatial analysis methods to characterize the isTIME of primary melanomas to identify associations between T cells, B cells, NK cells, Langerhans cells and patient outcome. Spatial profiling of 55 primary melanomas identified that immune neighborhood metaclusters (NMCs) enriched for either B cells, CD39+CD103+ CD8+ T cells or Langerhans cells were associated with improved rates of 5-year recurrence-free survival (RFS), while a BCA subtype harboring CD103-PD-1+ CD8+ T cells was associated with melanoma recurrence. Further analysis revealed that BCAs with higher proportions of CXCL13+ B cells were linked with reduced Breslow thickness and absence of ulceration in the primary tumor. Furthermore, the polarization of the isTIME toward B cell rather than CD38+ cell-dominant BCAs was associated with reduced ulceration and a smaller Breslow thickness. This study highlights the significance of immune neighborhoods containing CD39+CD103+ CD8+ T cells, CXCL13 expression in BCAs and their polarization as prognostic indicators in primary melanoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Melanoma Institute Australia, The University of Sydney, Sydney, Australia.
- Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
- Charles Perkins Centre, The University of Sydney, Sydney, Australia.
- Sydney Precision Data Science Center, The University of Sydney, Camperdown, Sydney, NSW, Australia.
- Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
- Department of Oncology, Sir Peter MacCallum, The University of Melbourne, Melbourne, Australia.
ORCID-Profile: James S Wilmott
Förderung
- National Health and Medical Research Council
- The University of Sydney
Zitieren
APA
Attrill, G. H., Canete, N., Feng, Y., Shteinman, E. R., Bai, X., Quek, C., Gide, T. N., Marsh-Wakefield, F., Patrick, E., Trigos, A. S., Palendira, U., Long, G. V., Scolyer, R. A., Vergara, I. A., & Wilmott, J. S. (2026). Immunospatial tumor microenvironment analysis identifies B cell aggregates associated with recurrence-free survival in primary melanoma. Cancer Immunology, Immunotherapy, 75(12). https://doi.org/10.1007/s00262-026-04514-9
Vancouver
Attrill GH, Canete N, Feng Y, Shteinman ER, Bai X, Quek C, et al. Immunospatial tumor microenvironment analysis identifies B cell aggregates associated with recurrence-free survival in primary melanoma. Cancer Immunology, Immunotherapy. 2026;75(12). doi:10.1007/s00262-026-04514-9
BibTeX
@article{Attrill2026,
author = {Attrill, Grace H and Canete, Nicholas and Feng, Yuzhou and Shteinman, Eva R and Bai, Xinyu and Quek, Camelia and Gide, Tuba Nur and Marsh-Wakefield, Felix and Patrick, Ellis and Trigos, Anna S and Palendira, Umaimainthan and Long, Georgina V and Scolyer, Richard A and Vergara, Ismael A and Wilmott, James S},
title = {Immunospatial tumor microenvironment analysis identifies B cell aggregates associated with recurrence-free survival in primary melanoma},
journal = {Cancer Immunology, Immunotherapy},
year = {2026},
volume = {75},
number = {12},
doi = {10.1007/s00262-026-04514-9}
}
EUVIMED